Publicaciones en colaboración con investigadores/as de Universidad de Cantabria (34)

2024

  1. Malondialdehyde Serum Levels in a Full Characterized Series of 430 Rheumatoid Arthritis Patients

    Journal of Clinical Medicine, Vol. 13, Núm. 3

2023

  1. Blood Composite Scores in Patients with Systemic Lupus Erythematosus

    Biomedicines, Vol. 11, Núm. 10

  2. Circulating levels of mitochondrial oxidative stress-related peptides MOTS-c and Romo1 in stable COPD: A cross-sectional study

    Frontiers in Medicine, Vol. 10

  3. Full characterization of the three pathways of the complement system in patients with systemic lupus erythematosus

    Frontiers in Immunology, Vol. 14

  4. HDL Cholesterol Efflux and the Complement System Are Linked in Systemic Lupus Erythematosus

    Journal of Clinical Medicine, Vol. 12, Núm. 16

  5. Hematological Composite Scores in Patients with Inflammatory Bowel Disease

    Journal of Clinical Medicine, Vol. 12, Núm. 23

  6. Mean Platelet Volume in a Series of 315 Patients with Rheumatoid Arthritis: Relationship with Disease Characteristics, including Subclinical Atherosclerosis and Cardiovascular Comorbidity

    Diagnostics, Vol. 13, Núm. 20

  7. Red Cell Distribution Width Association with Subclinical Cardiovascular Disease in Patients with Rheumatoid Arthritis

    Journal of Clinical Medicine, Vol. 12, Núm. 20

  8. Relationship between Disease Characteristics and Circulating Interleukin 6 in a Well-Characterized Cohort of Patients with Systemic Lupus Erythematosus

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

  9. Relationship between Malondialdehyde Serum Levels and Disease Features in a Full Characterized Series of 284 Patients with Systemic Lupus Erythematosus

    Antioxidants, Vol. 12, Núm. 8

  10. Relationship of Blood Inflammatory Composite Markers with Cardiovascular Risk Factors and Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis

    Life, Vol. 13, Núm. 7

  11. Relationship of Fibroblast Growth Factor 23 Serum Levels with Disease Characteristics in Systemic Lupus Erythematosus Patients

    Biomolecules, Vol. 13, Núm. 8

  12. Serum Levels of Lipoprotein Lipase Are Increased in Patients with Inflammatory Bowel Disease

    International journal of molecular sciences, Vol. 24, Núm. 6

2022

  1. Activity and safety of topical pimecrolimus in patients with early stage mycosis fungoides (PimTo-MF): a single-arm, multicentre, phase 2 trial

    The Lancet Haematology, Vol. 9, Núm. 6, pp. e425-e433

  2. Associations between serum mitokine levels and outcomes in stable COPD: an observational prospective study

    Scientific Reports, Vol. 12, Núm. 1

  3. Associations of serum sclerostin levels with body composition, pulmonary function, and exacerbations in COPD patients

    Pulmonology

  4. Bartonella Endocarditis in Spain: Case Reports of 21 Cases

    Pathogens, Vol. 11, Núm. 5

  5. Profibrotic Role of Inducible Heat Shock Protein 90α Isoform in Systemic Sclerosis

    Journal of immunology (Baltimore, Md. : 1950), Vol. 209, Núm. 1, pp. 38-48

  6. Silver jubilee: 25 years of the first demonstration of the direct effect of phosphate on the parathyroid cell

    Nefrologia, Vol. 42, Núm. 6, pp. 645-655

2021

  1. Apolipoprotein C3 and beta-cell dysfunction are linked in patients with systemic lupus erythematosus

    Clinical and experimental rheumatology